These findings demonstrate the potential of multiparametric imaging not only for preclinical research but also for clinical translation, where improved characterization of tumor subpopulations through imaging could enhance response prediction and therapeutic decision-making in HER2+ breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.